Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Cerilliant
Fuji
Moodys
Covington
Medtronic
Healthtrust
Express Scripts

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for Patent: RE34990

« Back to Dashboard

Summary for Patent: RE34990
Title: Oral therapeutic system having systemic action
Abstract:The invention relates to a therapeutic system for peroral administration and having systemic action, which system is in the form of a coated and/or laminated mono-compartment system for administering carbamazepine. The therapeutic system comprises (a) a wall made of a material which is permeable to water and impermeable to the components of the drug-containing core, (b) a core containing finely particulate carbamazepine as drug and, as auxiliaries, a protective colloid that inhibits the crystal growth of carbamazepine in the presence of water, a swellable hydrophilic polymer and, optionally, a water-soluble compound for inducing osmosis and/or further pharmaceutically acceptable excipients, and (c) a passageway through the wall (a) for delivering the core components to the environmental body fluid. The therapeutic system can be used as an anticonvulsive for the treatment of convulsive states, especially epileptic states.
Inventor(s): Khanna; Satish C. (Bottmingen, CH), Ruttimann; Theresa (Basel, CH)
Assignee: Ciba-Geigy Corporation (Ardsley, NY)
Application Number:08/133,814
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent RE34990
Patent Claim Types:
see list of patent claims
Compound; Delivery;

Drugs Protected by US Patent RE34990

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts
Baxter
Deloitte
McKinsey
Dow
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.